by Jörg Hartleib, Nicola Köhler, Richard B. Dickinson, Gursharan S

Slides:



Advertisements
Similar presentations
An anti-CD19 antibody inhibits the interaction between P-glycoprotein (P-gp) and CD19, causes P-gp to translocate out of lipid rafts, and chemosensitizes.
Advertisements

High molecular weight hyaluronic acid regulates osteoclast formation by inhibiting receptor activator of NF-κB ligand through Rho kinase  W. Ariyoshi,
Arterioscler Thromb Vasc Biol
Volume 58, Issue 5, Pages (November 2000)
Ligand binding to integrin αvβ3requires tyrosine 178 in the αv subunit
Activation of αIIbβ3 is a sufficient but also an imperative prerequisite for activation of α2β1 on platelets by Gerlinde R. Van de Walle, Anne Schoolmeester,
Correction of cross-linker sensitivity of Fanconi anemia group F cells by CD33-mediated protein transfer by Rebecca K. Holmes, Karine Harutyunyan, Maulik.
Transglutaminase-mediated oligomerization of the fibrin(ogen) αC domains promotes integrin-dependent cell adhesion and signaling by Alexey M. Belkin, Galina.
by Koji Nakamura, Alexander Malykhin, and K. Mark Coggeshall
The Small-Molecule Iron Transport Inhibitor Ferristatin/NSC Promotes Degradation of the Transferrin Receptor  Lior Horonchik, Marianne Wessling-Resnick 
by Kesheng Dai, Richard Bodnar, Michael C. Berndt, and Xiaoping Du
Essential role for phosphoinositide 3-kinase in shear-dependent signaling between platelet glycoprotein Ib/V/IX and integrin αIIbβ3 by Cindy L. Yap, Karen.
EphB2 and EphB4 receptors forward signaling promotes SDF-1–induced endothelial cell chemotaxis and branching remodeling by Ombretta Salvucci, Maria de.
Christopher L. Kepley, PhD, Bridget S. Wilson, PhD, Janet M
Activation of JAK2 in Human Vascular Endothelial Cells by Granulocyte-Macrophage Colony-Stimulating Factor by Raffaella Soldi, Luca Primo, Maria Felice.
Curcumin (diferuloylmethane) down-regulates the constitutive activation of nuclear factor–κB and IκBα kinase in human multiple myeloma cells, leading to.
by Xiuli An, Emilie Gauthier, Xihui Zhang, Xinhua Guo, David J
by Mineo Iwata, Lynn Graf, Norihiro Awaya, and Beverly Torok-Storb
Plasminogen-mediated matrix invasion and degradation by macrophages is dependent on surface expression of annexin II by Domenick J. Falcone, Wolfgang Borth,
by Nayna Mistry, Susan L. Cranmer, Yuping Yuan, Pierre Mangin, Sacha M
by Jing Huang, David G. Motto, David R. Bundle, and J. Evan Sadler
FOG-1 represses GATA-1-dependent FcϵRI β-chain transcription: transcriptional mechanism of mast-cell-specific gene expression in mice by Keiko Maeda, Chiharu.
ADAP interactions with talin and kindlin promote platelet integrin αIIbβ3 activation and stable fibrinogen binding by Ana Kasirer-Friede, Jian Kang, Bryan.
Cleaved high molecular weight kininogen binds directly to the integrin CD11b/CD18 (Mac-1) and blocks adhesion to fibrinogen and ICAM-1 by Nijing Sheng,
Agonist-induced aggregation of Chinese hamster ovary cells coexpressing the human receptors for fibrinogen (integrin αIIbβ3) and the platelet-activating.
by Zhengyan Wang, Tina M. Leisner, and Leslie V. Parise
Volume 129, Issue 3, Pages (September 2005)
Angiopoietins can directly activate endothelial cells and neutrophils to promote proinflammatory responses by Caroline Lemieux, Ricardo Maliba, Judith.
Caspases Mediate Tumor Necrosis Factor-–Induced Neutrophil Apoptosis and Downregulation of Reactive Oxygen Production by Kouhei Yamashita, Atsushi Takahashi,
Identification of FcγRIIa as the ITAM-bearing receptor mediating αIIbβ3 outside-in integrin signaling in human platelets by Brian Boylan, Cunji Gao, Vipul.
Nonhemolytic antigen loss from red blood cells requires cooperative binding of multiple antibodies recognizing different epitopes by James C. Zimring,
A role for the thiol isomerase protein ERP5 in platelet function
Cloning, expression, and functional characterization of the von Willebrand factor–cleaving protease (ADAMTS13)‏ by Barbara Plaimauer, Klaus Zimmermann,
Human peptidoglycan recognition protein S is an effector of neutrophil-mediated innate immunity by Ju Hyun Cho, Iain P. Fraser, Koichi Fukase, Shoichi.
by Bruno Bernardi, Gianni F. Guidetti, Francesca Campus, Jill R
Novel antimalarial antibodies highlight the importance of the antibody Fc region in mediating protection by Richard J. Pleass, Solabomi A. Ogun, David.
Hyaluronate-Enhanced Hematopoiesis: Two Different Receptors Trigger the Release of Interleukin-1β and Interleukin-6 From Bone Marrow Macrophages by Sophia.
Cytokine-inducible CD40 expression in human endothelial cells is mediated by interferon regulatory factor-1 by Andreas H. Wagner, Matthias Gebauer, Beatrix.
by Degang Zhong, Evgueni L
by Herbert Bosshart, and Ruth F. Jarrett
by Mi-Ae Kang, Su-Young Yun, and Jonghwa Won
by Chryso Kanthou, and Gillian M. Tozer
Apoptotic Vascular Endothelial Cells Become Procoagulant
by Juan M. Cárcamo, Oriana Bórquez-Ojeda, and David W. Golde
C1qTNF–related protein-1 (CTRP-1): a vascular wall protein that inhibits collagen-induced platelet aggregation by blocking VWF binding to collagen by Gerald.
John F. Öhd, Katarina Wikström, Anita Sjölander  Gastroenterology 
Brian Savage, Enrique Saldívar, Zaverio M Ruggeri  Cell 
by Subburaj Ilangumaran, Anne Briol, and Daniel C. Hoessli
Hydroxychloroquine inhibits calcium signals in T cells: a new mechanism to explain its immunomodulatory properties by Frederick D. Goldman, Andrew L. Gilman,
Interaction of kindlin-3 and β2-integrins differentially regulates neutrophil recruitment and NET release in mice by Zhen Xu, Jiayi Cai, Juan Gao, Gilbert.
CC chemokine ligand 20 partially controls adhesion of naive B cells to activated endothelial cells under shear stress by Anja Meissner, Olaf Zilles, Rosa.
Characterization of W1745C and S1783A: 2 novel mutations causing defective collagen binding in the A3 domain of von Willebrand factor by Anne F. Riddell,
Platelet Toll-like receptor expression modulates lipopolysaccharide-induced thrombocytopenia and tumor necrosis factor-α production in vivo by Rukhsana.
Regulation of plasminogen activation: a role for melanotransferrin (p97) in cell migration by Michel Demeule, Yanick Bertrand, Jonathan Michaud-Levesque,
Complement Receptor Type 1 (CR1, CD35) Is a Receptor for C1q
Inter-α inhibitor proteins maintain neutrophils in a resting state by regulating shape and reducing ROS production by Soe Soe Htwe, Hidenori Wake, Keyue.
A Mannose-Binding Receptor is Expressed on Human Keratinocytes and Mediates Killing of Candida albicans  Gyözö Szolnoky, Zsuzsanna Bata-Csörgö, Anna Sz.
Specific Synergy of Multiple Substrate–Receptor Interactions in Platelet Thrombus Formation under Flow  Brian Savage, Fanny Almus-Jacobs, Zaverio M Ruggeri 
Yang Shen, Monica Naujokas, Morag Park, Keith Ireton  Cell 
Tom E. Williams, Shanmugam Nagarajan, Periasamy Selvaraj, Cheng Zhu 
Volume 19, Issue 3, Pages (September 2003)
Structural Basis for Specific Recognition of Reelin by Its Receptors
Volume 96, Issue 3, Pages (February 1999)
Amphiregulin Exosomes Increase Cancer Cell Invasion
The Prolyl Isomerase Pin1 Functions in Mitotic Chromosome Condensation
Volume 15, Issue 9, Pages (September 2008)
Volume 12, Issue 6, Pages (June 2000)
Volume 23, Issue 2, Pages (August 2005)
by Fabian C. Verbij, Nicoletta Sorvillo, Paul H. P
Expression of MtrE by wild-type and mtr120 mutant strains.
Presentation transcript:

Protein A is the von Willebrand factor binding protein onStaphylococcus aureus by Jörg Hartleib, Nicola Köhler, Richard B. Dickinson, Gursharan S. Chhatwal, Jan J. Sixma, Orla M. Hartford, Timothy J. Foster, Georg Peters, Beate E. Kehrel, and Mathias Herrmann Blood Volume 96(6):2149-2156 September 15, 2000 ©2000 by American Society of Hematology

Interaction of vWF with soluble S. aureuscomponents or with SPA Interaction of vWF with soluble S. aureuscomponents or with SPA.(A) Western ligand and Western blot analyses of whole-cell staphylococcal lysates. Interaction of vWF with soluble S. aureuscomponents or with SPA.(A) Western ligand and Western blot analyses of whole-cell staphylococcal lysates. S. aureus Cowan 1, Newman, and NCTC 8325-4 lysates (2 μL) (lanes 1, 2, and 3, respectively) were separated on 7.5% SDS-PAGE, blotted on nitrocellulose, and incubated either with [DIG]-vWF in PBS (left), with polyclonal [DIG]-anti-SPA-Abs in PBS (right), or with PBS alone (center). Binding was detected using anti-DIG-Fab fragments and subsequent exposure with a chromogenic substrate (5 minutes). (B) Western ligand analysis of vWF binding to lysates of S. aureus wild-type (lanes 1, 2, and 3, respectively) and their respective Δspa deletion mutants (lanes 1′-3′). Experimental conditions identical to those in A (left). For enhanced detection sensitivity, gels were intentionally overloaded (20 μL lysate/lane), and blots were overexposed (30 minutes). (C) SDS-PAGE of rhvWF and Western ligand analysis of SPA binding. rhvWF expressed from Chinese hamster ovary cells (40 μg) was subjected to SDS-PAGE (7.5% gels), and gels were either stained with Coomassie blue (left) or used for blotting of vWF onto nitrocellulose (right). Membranes were subsequently blocked and incubated with [DIG]-rSPA, and rSPA binding was demonstrated in a color reaction described in A. Jörg Hartleib et al. Blood 2000;96:2149-2156 ©2000 by American Society of Hematology

SPR analysis of vWF interaction with rSPA-coupled CM5 sensor surfaces (solid lines) or uncoupled surfaces (dashed lines).(A) After instrument equilibration, vWF (250 μg/mL in HEPES buffer) was injected (➁) followed by HEPES buffer (➀) and surface regenerati... SPR analysis of vWF interaction with rSPA-coupled CM5 sensor surfaces (solid lines) or uncoupled surfaces (dashed lines).(A) After instrument equilibration, vWF (250 μg/mL in HEPES buffer) was injected (➁) followed by HEPES buffer (➀) and surface regeneration with glycine buffer (③) as described in “Materials and methods,” and RU was determined. (inset) Response measured as a function of time using different vWF concentrations (250/300/350/400/450/500 μg vWF/mL, lower through upper line) calculated by subtracting RUvWF-CM5-RUCM5. (B) Response curves after the injection of HSA (upper 2 lines) and BSA (lower 2 lines) followed by the injection of HEPES buffer. (C) Response after 4 injections of pooled human IgG (1060 nmol/L) (➁) followed by the injection of vWF (250 μg/mL) (➀). After regeneration of the surfaces, vWF (250 μg/mL) was injected (③), and surfaces were equilibrated and regenerated as in A. (D) Interaction of vWF and V8 protease-treated vWF with SPA. After immobilization of SPA (9300 RU), either vWF (100 μg/mL, 30 μL) (➁) or vWF digested with protease V8 (4 IU, 30 minutes at 37°C) (➀) was injected. After binding, surfaces were regenerated as described in A. Shown is the difference plot of signal obtained on [RUvWF-CM5 − RUCM5]. Jörg Hartleib et al. Blood 2000;96:2149-2156 ©2000 by American Society of Hematology

Flow cytometric analysis of binding of vWF to S. aureus Flow cytometric analysis of binding of vWF to S. aureus.Microorganisms (120 000 cells/mL) were incubated with FITC-vWF (150 μg/mL, 10 minutes at 21°C), then analyzed for binding by flow cytometry as described in “Materials and methods.” (A) Binding of vWF t... Flow cytometric analysis of binding of vWF to S. aureus.Microorganisms (120 000 cells/mL) were incubated with FITC-vWF (150 μg/mL, 10 minutes at 21°C), then analyzed for binding by flow cytometry as described in “Materials and methods.” (A) Binding of vWF to 3 S. aureus strains (▴, Cowan 1; ▪, Newman; ●, 8325-4). (B) Inhibition of vWF binding to S. aureus strains by the addition of excess unlabeled vWF over FITC-vWF (200 μg/mL) (symbol denotation as in A). (C, D) Inhibition of vWF binding toS. aureus Cowan 1 (C) and Newman (D) by the addition of polyclonal anti-SPA (▪) and IgG (●) antibodies. Shown are means ± SD (n = 3). RF indicates relative fluorescence. Jörg Hartleib et al. Blood 2000;96:2149-2156 ©2000 by American Society of Hematology

Binding of vWF to Δspa mutants and pSPA7235-complemented Δspa mutants Binding of vWF to Δspa mutants and pSPA7235-complemented Δspa mutants.Experimental conditions as described in Figure 3. Binding of vWF to Δspa mutants and pSPA7235-complemented Δspa mutants.Experimental conditions as described in Figure 3. (A) S. aureus NCTC 8325-4. (B) S. aureus Newman. ▪, wild-type strains; ●, Δspa mutants; ▴, complemented mutants. RF indicates relative fluorescence. Jörg Hartleib et al. Blood 2000;96:2149-2156 ©2000 by American Society of Hematology

Adhesion of S. aureus to vWF surfaces Adhesion of S. aureus to vWF surfaces.PMMA coverslips were preadsorbed with indicated concentrations of vWF, then incubated with [3H]-thymidine–labeled cells (4 × 106 CFU/mL) of either S. aureus 8325-4 (A), Cowan 1 (B), the respective Δspa mutants, or the p... Adhesion of S. aureus to vWF surfaces.PMMA coverslips were preadsorbed with indicated concentrations of vWF, then incubated with [3H]-thymidine–labeled cells (4 × 106 CFU/mL) of either S. aureus 8325-4 (A), Cowan 1 (B), the respective Δspa mutants, or the pSPA7235-complemented Δspa mutant in PBS/HSA (60 minutes at 37°C). ▪, wild-type strains; ●, Δspa mutants; ♦, complemented mutant. Shown are mean values ± SD of 3 determinations performed in quintuplicate. Jörg Hartleib et al. Blood 2000;96:2149-2156 ©2000 by American Society of Hematology

Adhesion of S. aureus Cowan 1 to vWF-PMMA in the presence of IgG Adhesion of S. aureus Cowan 1 to vWF-PMMA in the presence of IgG.Experimental conditions as in Figure 5. Adhesion of S. aureus Cowan 1 to vWF-PMMA in the presence of IgG.Experimental conditions as in Figure 5. After adsorption of vWF (50 μg/mL), adhesion assays were performed in the presence of increasing concentrations of human pooled IgG (Venimmun) (solid line). Control assays were performed with PMMA pretreated with PBS alone (dashed line). Shown are mean values ± SD of a quintuplicate determination. Jörg Hartleib et al. Blood 2000;96:2149-2156 ©2000 by American Society of Hematology

Adhesion of S. aureus 8325-4 and of DU 5875 to vWF adsorbed PMMA under defined flow conditions.PMMA slides were preincubated with vWF (50 μg/mL), mounted on a flow chamber, and perfused with S. aureus cells (5 × 107 CFU) (shear rate, 110/s). Adhesion of S. aureus 8325-4 and of DU 5875 to vWF adsorbed PMMA under defined flow conditions.PMMA slides were preincubated with vWF (50 μg/mL), mounted on a flow chamber, and perfused with S. aureus cells (5 × 107 CFU) (shear rate, 110/s). Adherent microorganisms visualized by light microscopy were determined over indicated time periods using automated image analysis. Shown are mean values of 10 fields ± SD. ▪, S. aureus 8325-4; ●, DU 5875. Jörg Hartleib et al. Blood 2000;96:2149-2156 ©2000 by American Society of Hematology